COVID-19. COVID-19, virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Prophylactic study: Those who live with a Covid-19 patient in a single house. Prophylactic study: Have not had Covid-19 (or its symptoms) so far. Prophylactic study: Maximum 7 days have passed since start of Covid-19 symptoms Treatment study: Covid-19 patients Treatment study: Maximum 7 days have passed since start of Covid-19 symptoms. Treatment study: Have not taken anti-virus drugs in the last 14 days
Exclusion criteria
Exclusion criteria: pregnant/ breast feeding women Underlying diseases heprsensitivity to herbal drug used in this study or their derivatives use of antiviral drugs in the last 2 weeks use of immune suppressor medicine use of serotonin inhibitor or othee sedative medicines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prophylactic study: clinical/lab confirmation of the disease. Timepoint: weekly. Method of measurement: examination- PCR test.;Prophylactic study: hospitalization due to Covid-19. Timepoint: weekly. Method of measurement: Hospital report.;Treatment study: general state of patient. Timepoint: weekly. Method of measurement: examination.;Treatment study: hospitalization due to Covid-19. Timepoint: weekly. Method of measurement: Hospital report.;Treatment study: death due to Covid-19. Timepoint: weekly. Method of measurement: Hospital report.;Prophylactic study: death due to Covid-19. Timepoint: weekly. Method of measurement: hospital report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Bojnourd University of Medical Sciences